Does Aetna Cover ADHD Treatment in New Hampshire? A 2026 Guide

Last updated: July 18, 2026

Aetna is one of New Hampshire’s largest commercial health insurers, covering hundreds of thousands of Granite State residents through employer-sponsored and individual marketplace plans. If you or a family member has been diagnosed with attention-deficit/hyperactivity disorder (ADHD), understanding exactly what Aetna may cover. And what New Hampshire’s electronic prescribing law requires. Can save significant time and out-of-pocket cost.

This guide breaks down Aetna’s 2026 ADHD formulary in New Hampshire, the CVS Caremark prior-authorization process, New Hampshire’s broad Electronic Prescribing of Controlled Substances (EPCS) law under RSA 318-B:21-a, and the mental health parity rights available to you under RSA 417-E:1.

Key facts at a glance:

• Aetna uses CVS Caremark as its pharmacy benefit manager (PBM) in New Hampshire.
• Generic stimulants (amphetamine salts, methylphenidate, lisdexamfetamine) are generally Tier 1. 2 on the CVS Caremark formulary.
• Brand-name stimulants (Adderall XR, Vyvanse brand, Concerta brand) typically require step therapy and are Tier 3. 4.
• New Hampshire RSA 318-B:21-a requires electronic prescribing (EPCS) for all Schedule II stimulants. Non-stimulant ADHD medications are not scheduled. EPCS does not apply to them.
• NH parity law RSA 417-E:1 requires that PA criteria and step therapy for ADHD medications be no more restrictive than for comparable medical/surgical treatments.
• Generic lisdexamfetamine (Vyvanse generic) is now available. Verify current tier placement with your plan.

Ready to get ADHD treatment through Klarity Health? Our network of 2,000+ licensed providers can evaluate, diagnose, and prescribe ADHD medication in New Hampshire. Often within days. See if you may qualify →

Aetna and CVS Caremark: How ADHD Medication Coverage Works in NH

Aetna processes most prescription drug claims through CVS Caremark, which maintains the formulary (covered drug list) that determines what your ADHD medications cost. CVS Caremark organizes drugs into cost tiers. Lower tiers typically have lower copays, while higher tiers may require prior authorization (PA), step therapy, or quantity limits before coverage is approved.

For ADHD, the formulary covers both stimulant medications (Schedule II controlled substances) and non-stimulant alternatives. The key distinction in New Hampshire is that Schedule II stimulants trigger mandatory electronic prescribing under RSA 318-B:21-a, while non-stimulant medications do not.

CVS Caremark ADHD Formulary: 2026 Tier and EPCS Overview

The table below reflects typical CVS Caremark formulary placement for common ADHD medications in 2026. Actual tier placement and PA requirements may vary by specific Aetna plan. Always verify with Aetna directly at 1-800-872-3862 or through the CVS Caremark portal.

Tier placement and PA requirements vary by specific Aetna plan. Verify current formulary status at aetna.com or call 1-800-872-3862.

New Hampshire EPCS Law: RSA 318-B:21-a and ADHD Stimulants

New Hampshire’s Electronic Prescribing of Controlled Substances law, codified at RSA 318-B:21-a, has one of the broadest scopes in the country. While many states restrict EPCS to Schedule II substances only, New Hampshire’s law covers Schedule II, III, and IV controlled substances. Meaning a wide range of medications trigger the electronic prescribing mandate.

For ADHD specifically, the practical impact is as follows:

• Schedule II stimulants (amphetamine and methylphenidate formulations): Electronic prescribing is mandatory under RSA 318-B:21-a. Paper prescriptions are generally not accepted for these medications in New Hampshire. Your provider must use a certified EPCS-enabled electronic health record (EHR) system to transmit prescriptions directly to CVS Caremark or a participating pharmacy.
• Non-stimulant ADHD medications (atomoxetine, viloxazine, guanfacine, clonidine, bupropion): None of these are classified as controlled substances under federal or New Hampshire scheduling. RSA 318-B:21-a does not apply to non-scheduled drugs. These medications can be prescribed and transmitted by standard (non-EPCS) methods.

The EPCS requirement does not affect whether Aetna or CVS Caremark will cover a stimulant. It is a prescribing method requirement, not a coverage gate. However, if a provider is not EPCS-certified, they cannot legally issue Schedule II prescriptions in New Hampshire, which would block access to stimulant therapy regardless of insurance coverage.

NH EPCS Scope vs. Other States

Prior Authorization for ADHD Medications: Aetna / CVS Caremark Process

Many brand-name stimulants and some generic formulations require prior authorization (PA) from Aetna before CVS Caremark will process the claim at the preferred tier. The typical PA process for ADHD medications involves:

1. Provider submission: Your prescribing provider submits a PA request through Availity (the primary electronic PA portal for Aetna in New Hampshire) or via fax to Aetna’s pharmacy PA unit. The request should include diagnosis documentation (DSM-5 criteria), prior medication history, and clinical rationale if requesting a brand-name product.
2. Step therapy compliance: For brand-name stimulants, Aetna’s formulary typically requires documentation that a generic equivalent was tried first (or a clinical reason why it is contraindicated). Non-stimulants are generally exempt from stimulant step therapy.
3. Initial decision timeline: Aetna is required under RSA 420-J (NH’s insurance code) to respond to standard PA requests within 3 business days and urgent PA requests within 24 hours.
4. Appeal rights: If Aetna denies a PA, you may request an internal appeal, then an external review through the NH Insurance Department (1-800-852-3416), and ultimately appeal to the NH Superior Court if necessary.

PA requirements for ADHD medications must comply with New Hampshire’s mental health parity law (RSA 417-E:1. See below). If the PA criteria are more restrictive than those applied to comparable medical or surgical treatments, that may constitute a parity violation.

New Hampshire Mental Health Parity: RSA 417-E:1

New Hampshire’s Mental Health Parity Law, RSA 417-E:1 et seq., requires fully insured commercial health plans issued in New Hampshire to provide mental health and substance use disorder (MH/SUD) benefits that are no more restrictive than medical and surgical benefits. This includes:

• Quantitative treatment limits: Visit limits, day limits, and dosage quantity limits for ADHD medications may not be more restrictive than comparable limits on physical health treatments unless actuarially justified.
• Non-quantitative treatment limits (NQTLs): PA requirements, step therapy protocols, and formulary tier placement for ADHD medications must be parity-compliant. Aetna cannot apply stricter PA criteria to ADHD stimulants than to comparable medical treatments without a documented comparative analysis.
• ERISA carve-out: Large employer self-funded health plans are governed by federal MHPAEA (29 U.S.C. § 1185a) rather than RSA 417-E:1, but the substantive parity standards are functionally equivalent.

If you believe Aetna is applying ADHD PA or step therapy requirements that are more restrictive than comparable medical/surgical treatments, you may file a parity complaint with the NH Insurance Department at 1-800-852-3416 or submit a request for a Comparative Analysis review.

Telehealth ADHD Treatment and RSA 415-J:2

New Hampshire’s telehealth parity law, RSA 415-J:2, requires fully insured plans to cover telehealth services at parity with in-person care. This means that if your Aetna plan covers in-person ADHD evaluations and medication management visits, it may be required to cover the same services delivered via telehealth. Including video-based ADHD assessments and follow-up appointments. At the same cost-sharing level.

Telehealth ADHD care typically includes initial diagnostic evaluation, prescription of stimulant or non-stimulant medication (EPCS-compliant for Schedule II), and ongoing medication management. Klarity Health providers in New Hampshire are fully EPCS-certified, ensuring that Schedule II stimulant prescriptions can be transmitted electronically in compliance with RSA 318-B:21-a.

ADHD Diagnoses That Aetna May Cover in New Hampshire

Aetna’s ADHD coverage in New Hampshire typically applies to the following DSM-5 diagnoses, subject to plan terms:

• ADHD, Predominantly Inattentive Presentation (F90.0)
• ADHD, Predominantly Hyperactive-Impulsive Presentation (F90.1)
• ADHD, Combined Presentation (F90.2)
• Other Specified ADHD (F90.8)
• Unspecified ADHD (F90.9)

Coverage may also extend to associated co-occurring conditions such as anxiety disorders, depression, and sleep disturbances, depending on plan terms. Verify covered diagnoses with Aetna at 1-800-872-3862 before scheduling an evaluation.

How to Verify Your Aetna ADHD Coverage in New Hampshire

1. Call Aetna member services at 1-800-872-3862 (TTY: 711) and ask for your mental health and pharmacy benefits summary. Request confirmation of your ADHD medication tier placement, PA requirements, and annual deductible.
2. Check the CVS Caremark formulary at caremark.com or 1-800-552-8159. Enter your plan ID to confirm current tier placement and PA requirements for the specific medication your provider intends to prescribe.
3. Confirm your provider is EPCS-certified. Any NH-licensed prescriber writing Schedule II stimulants must transmit prescriptions via an EPCS-enabled EHR. Klarity Health providers meet this requirement.
4. Request a Benefits Explanation of Coverage (EOC) document from Aetna for your specific plan year, which contains the binding formulary and PA terms.
5. Contact the NH Insurance Department at 1-800-852-3416 if you have questions about parity rights or need help resolving a coverage dispute.

ADHD Treatment at Klarity Health: Available to New Hampshire Residents

Klarity Health connects New Hampshire residents with a network of 2,000+ licensed providers. Including psychiatrists, physician assistants, and nurse practitioners. Who specialize in ADHD evaluation and treatment. Our providers are fully EPCS-certified, ensuring that Schedule II stimulant prescriptions comply with RSA 318-B:21-a and are transmitted directly to your preferred New Hampshire pharmacy.

Klarity Health may work with Aetna insurance plans in New Hampshire. Coverage and reimbursement vary by specific plan type. We recommend verifying your benefits before scheduling your first appointment.

Check if your Aetna plan may cover ADHD treatment at Klarity Health. See if you may qualify →

Frequently Asked Questions

Does Aetna cover Adderall in New Hampshire?

Generic amphetamine salt formulations (the generic equivalent of Adderall) are typically covered at Tier 1. 2 on the CVS Caremark formulary and are accessible with standard cost-sharing. Because amphetamine salts are Schedule II controlled substances, New Hampshire’s RSA 318-B:21-a requires that they be prescribed electronically via an EPCS-certified provider. Brand-name Adderall XR may require step therapy from the generic. Verify your specific plan’s terms with Aetna at 1-800-872-3862.

Is Vyvanse covered by Aetna in New Hampshire?

Generic lisdexamfetamine (the generic for Vyvanse) is now available and is typically Tier 2. 3 on CVS Caremark formularies. Brand-name Vyvanse is usually Tier 3. 4 with step therapy from the generic required. Both are Schedule II. EPCS is required for all lisdexamfetamine formulations in New Hampshire. Confirm current generic availability and tier placement with CVS Caremark at 1-800-552-8159.

Does Aetna cover non-stimulant ADHD medications in New Hampshire?

Yes. Non-stimulant medications including atomoxetine (Strattera generic), guanfacine ER (Intuniv generic), clonidine ER (Kapvay generic), and viloxazine (Qelbree) are generally covered on the CVS Caremark formulary. Because none of these are scheduled controlled substances, New Hampshire’s EPCS law does not apply to them. They can be prescribed by standard electronic or written methods. Generic non-stimulants are typically Tier 1. 2 and rarely require PA.

What does New Hampshire’s EPCS law mean for my ADHD prescription?

RSA 318-B:21-a requires that all Schedule II. IV prescriptions be transmitted electronically. ADHD stimulants are Schedule II, so your provider must use an EPCS-certified electronic health record system to send your prescription directly to the pharmacy. You cannot receive a paper prescription for a stimulant in New Hampshire. If your provider is not EPCS-certified, they cannot legally prescribe Schedule II medications in the state. Klarity Health’s providers are fully EPCS-certified.

What can I do if Aetna denies my ADHD medication PA?

You have the right to appeal. First, request a written denial letter explaining the reason. Then submit an internal appeal to Aetna within the timeframe specified in the denial. If the internal appeal is denied, you may request an Independent External Review through the NH Insurance Department at 1-800-852-3416. You may also file a parity complaint if you believe ADHD PA criteria are more restrictive than comparable medical treatments under RSA 417-E:1.

Does Aetna cover ADHD testing and evaluation in New Hampshire?

Aetna may cover psychological testing and ADHD diagnostic evaluations as a mental health benefit under fully insured plans subject to RSA 417-E:1. Coverage for neuropsychological testing varies significantly by plan and may require PA. A clinical evaluation by a licensed provider (psychiatrist, PA, or NP) for an ADHD diagnosis is typically a lower-cost entry point that is more consistently covered than full neuropsychological testing. Verify covered services with Aetna at 1-800-872-3862.

Contacts and Resources

• Aetna Member Services: 1-800-872-3862 (TTY: 711)
• CVS Caremark: 1-800-552-8159 | caremark.com
• Aetna Prior Authorization: Submit via Availity at aetna.com
• NH Insurance Department (complaints/appeals): 1-800-852-3416
• Klarity Health ADHD Treatment: helloklarity.com/service/adhd-treatment

Disclaimer: This guide is for general informational purposes only and does not constitute legal, medical, or insurance advice. Coverage terms vary significantly by specific Aetna plan, employer group, and plan year. Always verify your benefits directly with Aetna and CVS Caremark before scheduling a medical appointment or filling a prescription. Klarity Health makes no guarantees regarding insurance coverage or reimbursement. Formulary information reflects typical CVS Caremark placements as of 2026 and may change without notice.